France PPI: chemicals and pharmaceuticals
France PPI: chemicals and pharmaceuticals stood at 116 in Aug 2026, according to INSEE – Institut national de la statistique et des études économiques (BDM). It is one of the indicators in the PPI table (Value · Monthly), with a complete series running from Jan 2005 to Aug 2026. The complete series with an interactive chart, free to download.
This indicator in the PPI table
| Indicator | 08-2026 | 07-2026 | 06-2026 | 05-2026 | 04-2026 | 03-2026 | 02-2026 | 01-2026 | 12-2025 | 11-2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| All markets | |||||||||||
| CPF 20 and 21 - Chemicals and pharmaceuticals products: Base and preparations | 116 | 115.9 | 116.8 | 116.9 | 115.6 | 111.4 | 110.1 | 110.2 | 109.2 | 109.3 | |
| CPF 26 and 27 - Electrical, computer and electronic equipment | 113.1 | 112.9 | 112.5 | 112.3 | 111.9 | 111.1 | 111 | 111 | 110.5 | 110.5 |
Understanding france PPI: chemicals and pharmaceuticals
Basic chemical synthesis, petrochemical refining, fertilizer manufacturing, plastic raw materials, and finished pharmaceutical preparations define the scope of this index. The measurement tracks factory gate valuations for industrial chemicals, life-saving drugs, and medical formulations across all markets, omitting retail pharmacy markups and wholesale distribution fees. Unlike mechanical engineering sectors, this industry is intensely vulnerable to global crude oil price fluctuations, international patent expirations, and strict regulatory compliance standards that heavily dictate production capacity and pricing power.
Evaluating this data requires monitoring year-on-year comparisons to neutralize short-term feedstock volatility and sudden maintenance shutdowns at major chemical plants. Early monthly estimates frequently experience substantial revisions when complex multi-national enterprises submit delayed pricing adjustments. A frequent analytical error involves confusing this factory-level series with retail healthcare expenditure indices, which incorporate physician fees, insurance premiums, and pharmacy dispensing margins entirely absent from industrial producer gate pricing.
Frequently asked questions
- What industrial sectors are combined in this chemical and pharmaceutical index?
- It aggregates basic chemical manufacturing, petrochemicals, fertilizers, and finished medicinal pharmaceutical products.
- Why is feedstock volatility crucial for interpreting this series?
- Chemical production relies heavily on crude oil and gas derivatives, making factory prices sensitive to energy shocks.
- Does this index reflect the retail cost of prescription drugs?
- No, it measures factory gate prices and excludes pharmacy dispensing fees, insurance costs, and retail markups.